We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Hybrigenics Wins a USD 2.1 Million Yeast Two-Hybrid Contract
News

Hybrigenics Wins a USD 2.1 Million Yeast Two-Hybrid Contract

Hybrigenics Wins a USD 2.1 Million Yeast Two-Hybrid Contract
News

Hybrigenics Wins a USD 2.1 Million Yeast Two-Hybrid Contract

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Hybrigenics Wins a USD 2.1 Million Yeast Two-Hybrid Contract"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Hybrigenics announces the signature of a 3-year research services agreement worth USD 2.1 million with an US multinational life sciences company.

Under the agreement, Hybrigenics will build specific cDNA libraries from the living organisms of interest to the client company, perform yeast two-hybrid (Y2H) screens on demand, and compile exclusive bioinformatics databases of newly identified protein interactions.

The results will be visualized and exploited with Hybrigenics' highly sophisticated bioinformatics tools, such as its PIM-Rider software. As part of this 3-year commitment of USD 700,000 per year, Hybrigenics will designate dedicated program managers and ensure top priority completion of the Y2H screens requested by the client company.

"This contract shows that, in addition to its unique expertise and technology, Hybrigenics can also offer well-designed externalization contract conditions that can convince major life sciences organizations to work with Hybrigenics for reasons of speed, efficiency and cost-effectiveness against the background of the current economic environment that is driving rationalization," said Remi Delansorne, Hybrigenics' CEO.
Advertisement